COMMUNIQUÉS West-GlobeNewswire
-
Drop Off Toys 24/7 at 4 Ally Medical ER Locations for Austin Toy Drive
20/11/2026 -
NMDP appoints new board chair and welcomes new directors
20/11/2026 -
PMV Pharmaceuticals Announces Promising Updated Data From the PYNNACLE Phase 2 Pivotal Trial of Rezatapopt Monotherapy in Patients With TP53 Y220C-Mutated Advanced Solid Tumors
20/11/2026 -
BakingSlim Launch 2026 Advanced Baking Soda Slim Trick Recipe For Weight Loss Daily Metabolic Balance Capsules Supplement In USA.
20/11/2026 -
Genesis Molecular AI announces potency prediction breakthrough with Ruby, releases potency training dataset
20/11/2026 -
ABEM Celebrates First Year of Certifying Exam
20/11/2026 -
SRX Global Provides Update on Engineered T-Cell Strategy Following Pfizer–Starna Licensing Agreement
20/11/2026 -
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/11/2026 -
Erasca Reports Broad and Robust Phase 1 Clinical Efficacy and Favorable Safety Data for Pan-RAS Molecular Glue ERAS-0015
20/11/2026 -
For Smaller Travel Operators, Outsourcing Reservation Support Starts With Who Can Change a Booking
20/11/2026 -
Quanta Presents Class-Leading Monotherapy Data for QTX3034 in KRAS G12D-Mutant Advanced Endometrial Cancer at the EORTC-NCI-AACR Symposium
20/11/2026 -
HeartSciences Shareholders Approve Proposed Business Combination with Fortitude Mining
20/11/2026 -
Belite Bio Announces Extension of FDA Review Timeline for Tinlarebant NDA
20/11/2026 -
HYTN Innovations Inc. and Peptide Development Labs Inc. Announce Trading of PEPT Common Shares on the Canadian Securities Exchange
20/11/2026 -
iMDx Expands GraftAssure Utilization as First Patient Samples Arrive for GALACTIC Registry Study
20/11/2026 -
Annovis Secures FDA Agreement on Integrated Summary of Safety Plan, Combining Alzheimer’s and Parkinson’s Data Ahead of Buntanetap NDA
20/11/2026 -
Allogene Therapeutics to Host Events at American Society of Hematology Annual Meeting 2026 Highlighting the Potential of Allogeneic CAR T to Expand Patient Access
20/11/2026 -
Late-breaking Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA® (guselkumab) is the only advanced therapy to demonstrate MRI-confirmed improvements in spinal pain and stiffness
20/11/2026 -
JAMA Study Using Alamar Biosciences’ NULISA Assay Links Blood eMTBR-tau to Tau tangle Burden in Former Football Players with Advanced CTE
20/11/2026
Pages